Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genocea Biosciences Inc (NASDAQ:GNCA)

0.81
Delayed Data
As of Jan 17
 -0.27 / -25.00%
Today’s Change
0.79
Today|||52-Week Range
7.29
-30.17%
Year-to-Date
No recent news for Genocea Biosciences Inc.

Today’s Trading

Previous close1.08
Today’s open0.82
Day’s range0.79 - 0.85
Volume6,413,002
Average volume (3 months)1,090,687
Market cap$31.0M
Data as of 4:00pm ET, 01/17/2018

Growth & Valuation

Earnings growth (last year)-0.57%
Earnings growth (this year)-8.86%
Earnings growth (next 5 years)--
Revenue growth (last year)-64.93%
P/E ratioNM
Price/Sales496.14
Price/Book0.67

Competitors

 Today’s
change
Today’s
% change
CBMGCellular Biomedicine...-0.15-0.78%
VBLTVascular Biogenics L...+0.15+1.99%
KDMNKadmon Holdings Inc+0.11+2.51%
VBIVVBI Vaccines Inc-0.01-0.23%
Data as of 4:02pm ET, 01/17/2018

Financials

Next reporting dateFebruary 15, 2018
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$235.0K
Annual profit (last year)-$49.6M
Net profit margin-21,094.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Chip Clark
CFO &
Principal Accounting Officer
Jonathan Michael Poole
Corporate headquarters
Cambridge, Massachusetts

Forecasts